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PrP-dependent association of prions with splenic but not
circulating lymphocytes of scrapie-infected mice
Abstract
An intact immune system, and particularly the presence of mature B lymphocytes, is crucial for mouse
scrapie pathogenesis in the brain after peripheral exposure. Prions are accumulated in the
lymphoreticular system (LRS), but the identity of the cells containing infectivity and their role in
neuroinvasion have not been determined. We show here that although prion infectivity in the spleen is
associated with B and T lymphocytes and to a lesser degree with the stroma, no infectivity could be
detected in lymphocytes from blood. In wild-type mice, which had been irradiated and reconstituted
with PrP-deficient lymphohaematopoietic stem cells and inoculated with scrapie prions, infectivity in
the spleen was present in the stroma but not in lymphocytes. Therefore, splenic B and T lymphocytes
can either synthesize prions or acquire them from another source, but only when they express PrP.
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An intact immune system, and particularly the presence
of mature B lymphocytes, is crucial for mouse scrapie
pathogenesis in the brain after peripheral exposure.
Prions are accumulated in the lymphoreticular system
(LRS), but the identity of the cells containing infectivity
and their role in neuroinvasion have not been deter-
mined. We show here that although prion infectivity
in the spleen is associated with B and T lymphocytes
and to a lesser degree with the stroma, no infectivity
could be detected in lymphocytes from blood. In wild-
type mice, which had been irradiated and reconstituted
with PrP-deficient lymphohaematopoietic stem cells
and inoculated with scrapie prions, infectivity in the
spleen was present in the stroma but not in lympho-
cytes. Therefore, splenic B and T lymphocytes can
either synthesize prions or acquire them from another
source, but only when they express PrP.
Keywords: B lymphocytes/follicular dendritic cells/
prions/PrP knockout mice/T lymphocytes
Introduction
Intracerebral (i.c.) inoculation of mice with scrapie agent
results in a rise of infectivity in the spleen, weeks or
months before the brain is affected. However, in the case of
non-experimental forms of spongiform encephalopathies,
such as sheep scrapie, BSE or iatrogenic forms of
Creutzfeldt–Jakob disease (CJD), the agent usually enters
from the periphery; intraperitoneal (i.p.) inoculation of
mice with scrapie prions is therefore a more realistic
model. This procedure results in rapid accumulation of
infectious agent in the spleen and other tissues of the
lymphoreticular system (LRS) (Eklund et al., 1967;
Pattison and Jones, 1968; Fraser and Dickinson, 1970;
Mould et al., 1970), following which prions are probably
transported along tracts of the peripheral nervous system
to enter the brain, presumably via the spinal cord
(Kimberlin and Walker, 1980, 1988, 1989; Beekes et al.,
1996) or the N.vagus (Beekes et al., 1998). Transport
from the periphery to the central nervous system (CNS)
depends on elements of the LRS, as evidenced by the fact
that development of CNS disease after i.p. inoculation
with scrapie is impaired or abolished in mice with various
forms of immunodeficiency, such as SCID, RAG–/– or
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µMT mice, while i.c. inoculation continues to be fully
effective (O’Rourke et al., 1994; Fraser et al., 1996;
Lasmezas et al., 1996; Taylor et al., 1996; Brown et al.,
1997; Klein et al., 1997).
Results
Determination of scrapie infectivity in peripheral
blood leukocytes and fractionated splenocytes
In a first experiment, we analysed spleens of wild-type
(129/Sv-C57BL/6) mice 34 days after i.p. inoculation with
RML prions. Spleens were fractionated into pulp and
stroma. B and T cells were purified from the pulp fraction
by magnetic-activated cell sorting (MACS) followed by
complement lysis of B cells in the T-cell fraction and vice
versa. Finally, viable cells were isolated by density gradient
centrifugation. This three-step procedure led consistently
to highly purifed T- and B-lymphocyte preparations devoid
of detectable cross-contamination, as shown by fluores-
cence-activated cell sorting (FACS) analysis (Figure 1),
in 5–10% yield. In addition, a non-B, non-T cell population
was obtained by depleting splenocytes of B and T lympho-
cytes by MACS; this fraction contained ø2% T but no
detectable B lymphocytes. The cell preparations and the
stroma fraction were analysed for infectivity by endpoint
titration (Brandner et al., 1996; Fischer et al., 1996) (Table
I). Total splenocytes had ~3.5 log LD50 units per 106 cells,
and both B and T cells showed infectivity titres within
the same order of magnitude, 3.4 and 3.5 log LD50 units
per 106 cells, respectively. Strikingly, the non-B, non-T
cell population contained only ~1 log LD50 unit per 106
cells (which could be attributed to the ø2% contamination
by T lymphocytes), arguing that prion infectivity in the
splenocyte fraction was not due to unspecific contamina-
tion with infectivity released from the stromal fraction
(Clarke and Kimberlin, 1984). The pulp of a spleen
contains 2–43108 cells, ~80% of which are lymphocytes
(Binder et al., 1997). Inasmuch as the purified B and T cells
were representative of their class as regards infectivity,
~30033.5 log LD50 units 5 6 log LD50 units of infectivity
were associated with the pulp and ~4.3 log LD50 units
with the stroma of one spleen (Figure 2). Essentially all
infectivity detected in total spleen extracts was accounted
for by the fractions. There was ~50 times more infectivity
associated with lymphocytes than with stroma. Clarke and
Kimberlin (1984) have reported about equal distribution
of infectivity between pulp and stroma; however, their
data were obtained with mouse and scrapie strains different
from ours.
These findings suggested that lymphocytes might be
responsible for spreading prions through the organism.
We therefore determined the infectivity of peripheral blood
leukocytes (PBLs) from the same animals whose spleens
had been analysed. We were surprised to find that despite
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Fig. 1. Flow cytometric analysis of splenocytes and purified splenocyte fractions. Splenocytes from wild-type mice 34 days after i.p. inoculation with
RML scrapie agent were fractionated as described in the Materials and methods, and subjected to FACS analysis. More than 99% of the cells in the
purified B cell fraction were positive for the B-cell marker B220 and negative for the T-cell marker CD3. Similarly, .99% of purified cells in the
T-cell fraction were positive for CD3 and negative for B220. The same results were obtained whether or not the cells were gated for lymphocytes by
forward and side scattering. Ordinate, cell counts; abscissa, logarithm of fluorescence intensity.
Table I. Infectivity in spleen cell fractions and PBLs of scrapie-infected micea
Fraction Cell No. or Tg94/IRF Prnp1/1 Prnp1/1[FLC-Prnp0/0]
dilution
Inc. time n/No. Inc. time n/No. Inc. time n/No.
Splenocytes 106 n.d. n.d. .200 (0/4)
105 88, 90 (2/2) 81, 86 (2/2) n.d.
104 106.5 6 18 (4/4) 89 6 5 (4/4)
103 108, 125 (2/4) 106 6 7 (4/4)
102 .200 (0/4) .200 (0/4)
B cells 23105 n.d. n.d. .200 (0/4)
23104 106 6 10 (4/4) 88 6 2 (4/4) n.d.
23103 98, 114 (2/4) 102 614 (4/4)
23102 .200 (0/4) 91 (1/4)
T cells 105 n.d. n.d. .200 (0/4)
104 109, 110 (2/4) 94 6 8 (4/4) n.d.
103 .200 (0/4) 95, 121 (2/2)
102 .200 (0/4) .200 (0/4)
Non-B/T cells 53105 108 (1/4) 112 6 14 (3/4) .200 (0/4)
53104 n.d. .200 (0/4) n.d.
PBL 106 .200 (0/4) .200 (0/4) .200 (0/4)
Stroma homogenate undiluted 69 6 2 (4/4) 72 6 3 (4/4) 83 6 2 (4/4)
10–2 80, 94 (2/4) 108 6 20 (3/4) n.d.
10–4 .200 (0/4) .200 (0/4)
aWild-type mice (Prnp1/1), transgenic Prnp0/0 mice overexpressing PrP in spleen (Tg94IRF) and wild-type mice irradiated and reconstituted with
FLCs from Prnp0/0 mice (Prnp1/1[FLC-Prnp0/0]) were inoculated i.p. with RML prions, spleens were recovered after 34 days and processed as
described in the Materials and methods section. The number of cells indicated or a 1% stroma homogenate at the dilution indicated was inoculated
intracerebrally into indicator mice and the time to disease (inc. time) was recorded. n/No., number of animals succumbing to scrapie/number
inoculated. n.d., not done.
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Fig. 2. Distribution of prion infectivity in spleen fractions and peripheral blood leukocytes of scrapie-infected mice. Serial 10-fold dilutions of
splenocytes, splenocyte fractions, spleen stroma homogenate or PBLs were inoculated intracerebrally into groups of four indicator mice and the
incubation time to terminal scrapie disease was determined. Infectivity titres were calculated by the endpoint titration method (Reed and Muench,
1938) from the data given in Table I, assuming 33108 lymphocytes/spleen, of which 65% were B and 35% T lymphocytes. The detection limit of
the infectivity assay corresponds to 100 LD50 units per spleen.
the relatively high infectivity associated with splenic B and
T cells, intracerebral inoculation of 106 PBLs from buffy
coat did not cause disease in any of four indicator mice
(Table I). Because ~80% of murine PBLs are lymphocytes
(Binder et al., 1997), ,1 LD50 unit of infectivity was
associated with 83105 lymphocytes; the specific infectiv-
ity of peripheral lymphocytes was therefore at least 2000–
3000 times less than that of splenic lymphocytes.
We verified the infectivity measurements in a second,
similar experiment, using mice transgenic for a cluster
consisting of the PrP coding region under the control of
a hybrid immunoglobulin heavy chain enhancer/IRF-1
promoter (Yamada et al., 1991). These mice, designated
Tg94/IRF, overexpress PrP .1000-fold in spleen and
.100-fold in thymus, while PrP in brain is 0.05 of that
in wild-type (Raeber et al., 1999). After i.p. inoculation
with 106 LD50 units of the RML mouse prions, wild-type
mice developed scrapie after ~195 days whereas Tg94/
IRF mice developed disease after ~450 days, presumably
because of the low level expression of PrP in the brain.
Between 2 weeks and 6 months after inoculation, spleno-
cytes from Tg94/IRF and wild-type mice had essentially
the same titre: ~7 log LD50 U/ml of 10% homogenate.
There was no detectable infectivity in brain as compared
with 8 log LD50 U/ml of 10% homogenate for wild type.
However, 1 year after inoculation, the brain showed a
prion titre of ~7 log LD50 U/ml of 10% homogenate
(Raeber et al., 1999).
Spleens of Tg94/IRF mice, collected 34 days after i.p.
inoculation, were fractionated as before. Again, infectivity
was associated with purified B and T cells and stroma,
but not with the non-B, non-T cell fraction or with PBLs
(,1 LD50 unit per 106 cells; Table I; Figure 2).
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Association of infectivity with splenic lymphocytes
is dependent on PrP expression
We have shown previously that prion replication does not
occur in the spleen of Prnp0/0 mice (Bu¨eler et al., 1993).
Moreover, reconstitution of the LRS of Prnp0/0 mice with
PrP-expressing fetal liver cells (FLCs) restored prion accu-
mulation in the spleen (Bla¨ttler et al., 1997). To assess
whether the association of infectivity with lymphocytes was
specific or adventitious, we lethally irradiated Prnp1/1 mice
and reconstituted them with FLCs derived from Prnp0/0
mice. PCR analysis of splenocytes, PBLs, stroma and tail
tissue confirmed that these mice had undergone successful
reconstitution, and FACS analysis of lymphocytes demon-
strated the Prnp0/0 origin of these cells (data not shown).
Spleens from these mice, 34 days after i.p. inoculation with
RML prions, were fractionated and analysed: no infectivity
was found in either total splenocytes (,1 LD50 unit per 106
cells), or in purified B or T lymphocytes (,1 LD50 unit per
105 cells). However, prion titres in the stromal fraction were
not significantly different from those in wild-type mice
(Table I; Figure 2). Two-colour immunofluorescence ana-
lysis of spleen sections stained with follicular dendritic cell
marker FDC-M1 and a polyclonal antibody to PrP revealed
PrP accumulation in FDCs (Klein et al., 1998). From these
results, we conclude that scrapie infectivity in spleens of
irradiated mice reconstituted with PrP0/0 lymphohaemo-
poietic stem cells is probably associated with FDCs and that
splenic lymphocytes devoid of PrP fail to produce or to take
up scrapie infectivity.
Discussion
It is remarkable that despite the .1000-fold overexpression
of PrP in the spleen of Tg94/IRF mice, the prion titre in this
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organ was not higher than that in wild-type mice. Either the
level of PrP is not the limiting factor for the formation of
prions or else overexpression is not occurring in the cells in
which prions are formed. Similarly, at the terminal stage
of scrapie, the prion titre in brains of tga20 mice, which
overexpress PrP 5- to 8-fold, is about the same as in wild-
type, although the incubation times for the transgenic and
wild-type mice are 60 and 160 days, respectively (Fischer
et al., 1996).
The experiments described here show that in the spleen
of i.p. scrapie-infected wild-type mice, prions are associ-
ated with B and T lymphocytes as well as with the stroma,
but not with the pulp-derived non-B, non-T cell fraction
which consists mainly of monocytes and granulocytes
(Binder et al., 1997). Moreover, there was ,1 LD50 unit
of infectious agent in ~106 lymphocytes recovered from
peripheral blood, i.e. the specific infectivity of lymphocytes
in PBLs was at least 2000-fold lower than in the spleen.
Because a mouse has ~23107 circulating lymphocytes,
there would be ,20 LD50 units of cell-associated infectiv-
ity, if any, circulating at one time.
Were the prions associated with splenic lymphocytes
generated in these cells or were they acquired from other
sources? Unspecific contamination is unlikely because the
specific infectivity of non-B, non-T cells derived from
the pulp was 2000–3000 times less than that of B or
T lymphocytes and because B and T lymphocytes devoid
of PrP failed to acquire infectivity in a spleen whose
stroma did contain infectious agent. We have generated
mice expressing PrP exclusively on T cells (Raeber
et al., 1996) or on B cells (F.Montrasio, A.J.Raeber and
C.Weissmann, unpublished results) and i.p. inoculation of
such mice with scrapie agent failed to result in disease or
accumulation of infectivity in the spleen. If lymphocytes
are at all able to replicate scrapie agent, then perhaps they
can do so only in the context of other types of PrP-
bearing cells.
Infectivity in the stromal component of peripheral
lymphoid organs is thought to reside in radiation-resistant
post-mitotic cells (Fraser and Farquhar, 1987; Fraser et al.,
1989). A prime candidate is the follicular dendritic cell,
because the pathological isoform of the prion protein,
PrPSc, co-localizes with FDCs in mice inoculated with
CJD or scrapie agent (Kitamoto et al., 1991; McBride
et al., 1992; Muramoto et al., 1992). Because lymphocytes
interdigitate with FDCs (Heinen et al., 1995), they might
have acquired prions or prion-containing, torn-off mem-
brane fragments from the latter during the isolation proced-
ure. However, when wild-type mice were irradiated and
reconstituted with PrP-less FLCs, no infectivity was found
on splenic lymphocytes, which means that if this ‘transfer’
hypothesis is correct, the postulated adhesion of scrapie
agent is dependent on the presence of PrP on lymphocytes;
PrP would then function as the receptor for the infectious
agent. A likely source of prions would be the FDCs.
Why is infectivity found on splenic but not on circulating
lymphocytes? Perhaps only distinct subsets of splenic
lymphocytes carry infectivity and these do not enter the
blood stream, or perhaps prion-carrying splenic lympho-
cytes are eliminated in the spleen. Alternatively, prions
may attach to lymphocytes only during the preparation
procedure, albeit through a PrP-dependent interaction.
As regards the role of lymphocytes in the spread of
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infectivity from the periphery to the CNS, it would seem
that circulating, prion-bearing B cells are not required,
not only because they were not detected outside the LRS,
but because reconstitution of irradiated wild-type mice
(Bla¨ttler et al., 1997) or immunodeficient mice (Klein
et al., 1998) with LRS devoid of PrP restored invasion of
the CNS by prions following i.p. inoculation.
Materials and methods
Scrapie infection
RML is a mouse-adapted scrapie isolate (Chandler, 1961). It was
passaged in Swiss CD-1 mice obtained from Charles River Laboratories.
Inocula were 10% (w/v) homogenates of RML-infected CD-1 mouse
brains in 0.32 M sucrose. Mice were infected i.p. with 100 µl of a
10-fold dilution of the inoculum in phosphate-buffered saline (PBS)
containing 5% bovine serum albumin (BSA).
Bone marrow reconstitution
Eight-week-old Prnp1/1 mice (129/Sv3C57BL/6) were lethally irradi-
ated and reconstituted with FLCs from E14.5–15.5 Prnp0/0 (129/
Sv3C57BL/6) embryos as described previously (Bla¨ttler et al., 1997).
The extent of reconstitution was assessed by FACS and PCR 6–8 weeks
after grafting. Inoculation with mouse scrapie prions was carried out 12
weeks after reconstitution.
Preparation of splenocytes and stroma
Spleens were collected from mice 34 days after i.p. inoculation with the
RML strain of prions. Splenocytes were obtained by forcing spleens
through a fine mesh platinum wire net. Cell suspensions were prepared
in PBS with 1% BSA, 5 mM EDTA and 0.01% sodium azide (MACS
buffer). The stromal fraction was recovered from the net and a 1% (w/v)
homogenate in PBS–5% BSA was prepared by forcing the suspension
through an 18 gauge needle. The homogenate was digested with
1 mg/ml collagenase D (Boehringer Mannheim) for 60 min at 37°C and
sonicated (Branson Sonifier, maximal output) four times for 1 min.
B and T cell purification
Splenocytes were incubated with anti-mouse B220 or Thy1.2 antibodies
conjugated with super-paramagnetic microbeads (Milteny Biotec GmbH,
Germany) for 15 min at 4°C and applied to a pre-filled and washed A2
column fixed onto the VARIO MACS (Milteny Biotec GmbH). Un-
labelled cells were eluted with MACS buffer using a 23 gauge syringe
attached to the column outlet as flow resistor. The column was removed
from the magnet and cells were backflushed using a syringe attached to
the column outlet. The column was fixed to the magnet and the cell
suspension was allowed to enter the column. Unlabelled cells were again
rinsed out with MACS buffer. Finally, the column was removed from
the magnet and labelled cells were eluted by rinsing the column with
MACS buffer.
B and T cell depletion
Splenocytes were incubated with anti-mouse B220 and anti-mouse
Thy1.2 antibodies conjugated with super-paramagnetic microbeads for
15 min at 4°C and applied to a CS column fixed onto the VARIO
MACS. Unlabelled cells were eluted with MACS buffer as described
above. The flow-through fraction was once again loaded onto a CS
column and unlabelled cells eluted in MACS buffer.
Complement lysis
MACS-purified B- and T-cell fractions were purified further by comple-
ment lysis of B cells in the T-cell fraction and vice versa. Cells were
pelleted and resuspended in RPMI-1640 with 25 mM HEPES (pH 7.4)
and 0.3% BSA [cytotoxicity medium (CM)] to give 1–33107 cells/ml.
For B cell depletion, cells were incubated with a 1:200 dilution of rat
anti-mouse LR1 antibody (clone LR6.2B6D6.C9, Serotec). For T cell
depletion, cells were incubated with a 1:400 dilution of mouse anti-
mouse Thy1.2 antibody (clone F7D5, Serotec) at 4°C for 60 min. The
cells were resuspended to the original density in CM containing 20%
Low-tox-M rabbit complement (Cedarlane, Ontario, Canada) and incub-
ated for 60 min at 37°C. Viable lymphocytes were separated from dead
cells and debris by centrifugation over Lympholyte-M as recommended
by the manufacturer (Cedarlane, Ontario, Canada).
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Isolation of PBLs from whole blood
PBLs were isolated from whole blood by density gradient centrifugation
using Lympholyte-M as recommended by the manufacturer (Cedarlane,
Ontario, Canada).
FACS analysis
Single-cell suspensions were prepared in PBS, 2% fetal calf serum,
20 mM EDTA, 0.01% sodium azide (FACS buffer). For flow cytometry,
cells were stained with saturating concentrations of fluorescein-conjug-
ated antibodies (1 µg/106 cells) for 30 min at 4°C and washed in FACS
buffer. Data acquisition and analysis were performed with an EPICS XL
(Coulter) flow cytometer. Dead cells were gated out by forward and
side scatter properties. Monoclonal antibodies used were fluorescein
isothiocyanate (FITC)-conjugated RA3-6B2 (B220) (Gibco-BRL) and
FITC-conjugated KT3 (CD3) (Serotec).
Determination of infectivity
Cell fractions were collected by centrifugation for 10 min at 1000 r.p.m.
and diluted serially in PBS–5% BSA. Tga20 mice (Fischer et al., 1996)
were inoculated i.c. with 30 µl of inoculum into the right parietal lobe,
using a 26 gauge hypodermic needle. Prion titres were estimated from
the incubation times (Brandner et al., 1996) and/or dilution endpoints
(Reed and Muench, 1938).
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